Review of lithium-ion batteries' supply-chain in Europe: Material flow analysis and environmental assessment

European legislation stated that electric vehicles' sale must increase to 35% of circulating vehicles by 2030, and concern is associated to the batteries' supply chain. This review aims at analysing the impacts (about material flows and CO2 eq emissions) of Lithium-Ion Batteries' (LIBs) recycling at full-scale in Europe in 2030 on the European LIBs' supply-chain. Literature review provided the recycling technologies' (e.g., pyro- and hydrometallurgy) efficiencies, and an inventory of existing LIBs' production and recycling plants in Europe. European production plants exhibit production capacity adequate for the expected 2030 needs. The key critical issues associated to recycling regard pre-treatments and the high costs and environmental impacts of metallurgical processes. Then, according to different LIBs' composition and market shares in 2020, and assuming a 10-year battery lifetime, the Material Flow Analysis (MFA) of the metals embodied in End of Life (EoL) LIBs forecasted in Europe in 2030 was modelled, and the related CO2 eq emissions calculated. In 2030 the European LIBs' recycling structure is expected to receive 664 t of Al, 530 t of Co, 1308 t of Cu, 219 t of Fe, 175 t of Li, 287 t of Mn and 486 t of Ni. Of these, 99% Al, 86% Co, 96% Cu, 88% Mn and 98% Ni will be potentially recovered by pyrometallurgy, and 71% Al, 92% Co, 92% Fe, 96% Li, 88 % Mn and 90% Ni by hydrometallurgy. However, even if the recycling efficiencies of the technologies applied at full-scale are high, the treatment capacity of European recycling plants could supply as recycled metals only 2%-wt of the materials required for European LIBs' production in 2030 (specifically 278 t of Al, 468 t of Co, 531 t of Cu, 114 t of Fe, 95 t of Li, 250 t of Mn and 428 t of Ni). Nevertheless, including recycled metals in the production of new LIBs could cut up 28% of CO2 eq emissions, compared to the use of virgin raw materials, and support the European batteries' value chain.

Closed-loop recycling of lithium iron phosphate cathodic powders via citric acid leaching

Lithium recovery from Lithium-ion batteries requires hydrometallurgy but up-to-date technologies aren't economically viable for Lithium-Iron-Phosphate (LFP) batteries. Selective leaching (specifically targeting Lithium and based on mild organic acids and low temperatures) is attracting attention because of decreased environmental impacts compared to conventional hydrometallurgy. This study analysed the technical and economic performances of selective leaching with 6%vv. H2O2 and citric acid (0.25-1 M, 25 °C, 1 h, 70 g/l) compared with conventional leaching with an inorganic acid (H2SO4 1 M, 40 °C, 2 h, 50 g/l) and an organic acid (citric acid 1 M, 25 °C, 1 h, 70 g/l) to recycle end of life LFP cathodes. After conventional leaching, chemical precipitation allowed to recover in multiple steps Li, Fe and P salts, while selective leaching allowed to recover Fe and P, in the leaching residues and required chemical precipitation only for lithium recovery. Conventional leaching with 1 M acids achieved leaching efficiencies equal to 95 ± 2% for Li, 98 ± 8% for Fe, 96 ± 3% for P with sulfuric acid and 83 ± 0.8% for Li, 8 ± 1% for Fe, 12 ± 5% for P with citric acid. Decreasing citric acid's concentration from 1 to 0.25 M didn't substantially change leaching efficiency. Selective leaching with citric acid has higher recovery efficiency (82 ± 6% for Fe, 74 ± 8% for P, 29 ± 5% for Li) than conventional leaching with sulfuric acid (69 ± 15% for Fe, 70 ± 18% for P, and 21 ± 2% for Li). Also, impurities' amounts were lower with citric acid (335 ± 19 335 ± 19 of S mg/kg of S) than with sulfuric acid (8104 ± 2403 mg/kg of S). In overall, the operative costs associated to 0.25 M citric acid route (3.17€/kg) were lower compared to 1 M sulfuric acid (3.52€/kg). In conclusion, citric acid could be a viable option to lower LFP batteries' recycling costs, and it should be further explored prioritizing Lithium recovery and purity of recovered materials.

Medial or Lateral, That Is the Question: A Retrospective Study to Compare Two Injection Techniques in the Treatment of Knee Osteoarthritis Pain with Hyaluronic Acid

Background: Mild-to-moderate knee osteoarthritis (KOA) can be successfully treated using intra-articular hyaluronic acid (IA-HA). The medial infrapatellar (MIP) approach and lateral infrapatellar (LIP) approach are two of the most used techniques for performing IA-HA, but it is still not clear which one is preferable. Objectives: The study aims to find the best knee injection technique between MIP and LIP approaches. Methods: In total, 161 patients were enrolled, divided into two groups (MIP or LIP). Each technique was performed once a week for three weeks. Patients were evaluated using the Numeric Rating Scale (NRS), Knee Injury and Osteoarthritis Outcome Score (KOOS) and Roles and Maudsley Score (RMS) at T0 (before the first injection), T1 (one week after the third injection) and T2 (six months after). Results: NRS, KOOS and RMS showed a statistically significant improvement in both groups at all the detection times, without significant differences. No differences were detected between the groups in terms of systemic effect effusions, while the MIP group presented a mildly higher number of bruises in comparison with the LIP group (p = 0.034). Conclusions: Both the IA-HA techniques are equally effective in measured outcomes. The MIP approach seems to produce some local and transient side effects. So, the choice of the LIP or MIP approach depends on the operator's skill and experience.

Assessing the environmental performances of waste-to-energy plants: The case-study of the EMAS-registered waste incinerators in Italy

This study evaluated the environmental performances of 15 Italian waste incineration (WI) plants registered to EMAS. From the EMAS Environmental Statements, the validated data related to 5 environmental aspects (emissions to air, energy consumption/production, waste production and reagent consumption) and 24 key indicators were analyzed to describe and assess the environmental performances of the plants in 2017-2019 in relation to the best available techniques associated emission levels (BAT-AELs) and other sectorial reference values. All air pollutants' average concentrations resulted significantly below the upper BAT-AELs, the majority under the lower BAT-AELs, with an overall slightly decreasing trend (-4.6%). The specific productions of bottom and other ashes were steady over time and just above the lower characteristic values. The specific energy consumption was higher than the average European performance and stable over time, while the specific reagent consumption was harder to evaluate, with results varying for the different reagents. An evaluation of the influence of the WI plants' characteristics on the environmental performances was also performed considering 13 different parameters (e.g., flue gas cleaning technologies, waste treatment capacity, etc.). A correlation analysis highlighted the positive influence of the pre-dedusting stages on overall emissions, specific reagents consumption and specific waste production, and of the plant size on the specific energy production. This study demonstrated that EMAS can provide a tool to evaluate the environmental performances of WI plants and compare different installations using certified data. It also highlighted the excellent performances of the Italian WI plants registered to EMAS compared to the sectorial references.

POS0887 CHORIORETINAL MICROVASCULAR INVOLVEMENT IN SYSTEMIC SCLEROSIS

Background

The optical coherence tomography angiography (OCTA) is a new non-invasive imaging technique that can detect flow and provide information about the vessel density (VD) at different layers in the eye. The ocular microvascular network has been only occasionally addressed as disease target in scleroderma (SSc) considering the relatively low prevalence of ocular symptoms in these patients.

Objectives

The study aims to evaluate retinal and choriocapillaris microvasculature in a group of SSc patients compared to matched controls (HC)and according to disease characteristics, capillaroscopy findings and pulmonary function tests.

Methods

VD was assessed through OCTA at the retinal superficial (SCP) and deep (DCP) capillary plexus, at the foveal avascular zone perimeter (FAZP) and at the choriocapillaris (CC) of 30 SSc patients compared to 30 sex- and age-matched subjects without any retinal disease.

Results

The SSc patients (age 57.3±10.0, female 86.7%) had diffuse cutaneous skin disease in 30.0% of the cases, an average disease duration of 10.4±7.2 yy, and anti-centromere and anti-Scl70 antibody positivity in 40.0%and in 30.0% of the cases, respectively. Compared to the HC, SSc showed an impaired VD at SCP (47.7±3.6 vs59.1±3.5%, p=0.009), DCP (50.0±6.7 vs 54.3±6.4%, p=0.015), FAZP (48.7±4.55 vs 51.0±3.55%, p=0.034) and CC(67.1±2.2 vs 68.6±1.7, p=.005). Moreover, in the SSc group, the presence of digital ulcers (46.7%),telangiectasias (43.3%) and interstitial lung disease (46.7%) was related to reduced VD at FAZP (46.8±4.1 vs50.3±4.3%, p=0.033), CC (66.1±1.4 vs 67.9±2.4%, p=0.004), and DCP (47.2±8.8 vs 51.9±4.3, p=0.004),respectively. Lastly, the average capillary density on capillaroscopy showed a positive correlation with VD at FAZP (r=0.474, p=0.008), DCP (r=0.414, p=0.023), and foveal CC (r=0.482, p=0.007) and there was also a correlation between CC and both DLco (r=0.467, p=0.009) and FVC/DLco (r=-0.436, p=0.004).

Conclusion

The SSc patients in our cohort showed lower ocular vessel density at different levels compared to HC. Furthermore, impaired VD at different levels of the eye correlates with the organ involvement and the degree of digital and pulmonary microvascular impairment. According to those data, the OCTA could be proposed as a biomarker tool to investigate the microvascular abnormalities in SSc.

Disclosure of Interests

None declared

Analysis of the influence of mobile phones' material composition on the economic profitability of their manual dismantling

This work presents a systematic characterisation of 100 waste mobile phones (73 feature phones and 23 smartphones) produced between 1989 and 2016. All items were inventoried and the evolvement of the relative abundances of their macro-components (mechanic and electro-mechanic parts, electronics and others) and materials was investigated. The average lifetime was 15.1 years for feature phones and 6.4 years for smartphones. The main component was plastic, on average 46%-wt. in feature phones and 37%-wt. in smartphones; over the years electronics' and plastic's amounts decreased (respectively 80% and 70%), while metal components' amount increased (12%). A cost-benefit analysis explored the profitability of the management of waste mobile phones through manual dismantling followed by the sale of the separated components and materials. The average cost of manual dismantling was estimated as 6.93 € per item according to EU average labour costs and 1.50 € per item based on minimum EU labour costs. According to the performed economic analysis, the actual market prices for the potentially recoverable materials and components of waste mobile phones were not able (particularly mixed plastics) to counterbalance the costs of manual dismantling according to the European standard labour costs.

Evaluation of the influence of filter medium composition on treatment performances in an open-air green wall fed with greywater

According to the European Research and Innovation Policy Agenda, nature-based solutions (NBSs) are key technologies to improve the sustainability of urban areas. Among NBSs, green walls have been recently studied for several applications, among the others the treatment of lowly polluted wastewater flows as greywater (GW, e.g. domestic wastewater excluding toilet flushes). This work is aimed at the evaluation of the influence of four additives (compost, biochar, granular activated carbon, polyacrylate) mixed with a base filter medium made of coconut fibre and perlite, on the performances of a green wall fed in batch mode with synthetic GW. The green wall was operated with a high hydraulic loading rate of GW (740.8 L/m²/day) in open-air winter conditions (3.5-15 °C measured for GW) between January and April. The performances of the green wall have been assessed though the monitoring every 1-2 weeks of physicochemical and biological parameters (pH, electric conductivity, total suspended solids, dissolved oxygen, BOD₅ and COD, nitrogen and phosporus compounds, chlorides and sulphates, anionic surfactants and E. coli). Removal performances were excellent for BOD₅ (>95%) and E.coli (>98%) for all additives; compared to the base medium, biochar was the best performing additive over the highest number of parameters, achieving removals equal to 51% for COD, 47% for TKN and nitric nitrogen and 71% for anionic surfactants. Compost also achieved high removal performances, but the frequent clogging events occurred during the monitoring period do not make its use recommendable. Granular activated carbon and the combination of biochar and polyacrylate performed better than the base medium, but only about the removal of nitric nitrogen. These results demonstrated that, in the considered experimental boundaries, biochar could improve the overall treatment performances of a green wall fed by GW and operated in challenging conditions.

Recovery of Waste Polyurethane from E-Waste. Part II. Investigation of the Adsorption Potential for Wastewater Treatment

This study explored the performances of waste polyurethane foam (PUF) derived from the shredding of end-of-life refrigerators as an adsorbent for wastewater treatment. The waste PUF underwent a basic pre-treatment (e.g., sieving and washing) prior the adsorption tests. Three target pollutants were considered: methylene blue, phenol, and mercury. Adsorption batch tests were performed putting in contact waste PUF with aqueous solutions of the three pollutants at a solid/liquid ratio equal to 25 g/L. A commercial activated carbon (AC) was considered for comparison. The contact time necessary to reach the adsorption equilibrium was in the range of 60–140 min for waste PUF, while AC needed about 30 min. The results of the adsorption tests showed a better fit of the Freundlich isotherm model (R² = 0.93 for all pollutants) compared to the Langmuir model. The adsorption capacity of waste PUF was limited for methylene blue and mercury (K_f = 0.02), and much lower for phenol (K_f = 0.001). The removal efficiency achieved by waste PUF was lower (phenol 12% and methylene blue and mercury 37–38%) compared to AC (64–99%). The preliminary results obtained in this study can support the application of additional pre-treatments aimed to overcome the adsorption limits of the waste PUF, and it could be applied for “rough-cut” wastewater treatment.

Investigation of the anaerobic digestion of cosmetic industrial wastes: Feasibility and perspectives

This study assessed the anaerobic digestion (AD) of wastes deriving from cosmetics production: sludge from onsite wastewater treatment plant (sWWTP), residues of shampoo/conditioner (RSC) and sludge from mascara production (MS), considered as single substrates and as mixture according to the produced amounts (54 %-wt sWWTP, 31 %-wt RSC, 13 %-wt MS, plus 2 %-wt food waste from the canteen, FW). Total COD (COD_T) was 624-1436 g O₂/kg _VS, while soluble COD was 5-23 %-wt of COD_T. AD tests at 35 °C achieved the following biogas yields: 0.10 Nm³/kg_vs (70 %-v/v methane) for sWWTP; 0.07 Nm³/kg_vs (62 %-v/v methane) for RSC; 0.04 Nm³/kg_vs (67 %-v/v methane) for MS. The mixed substrates underwent physico-chemical pre-treatments (thermo-alkaline, TA: 120 min at 50 °C; thermo-alkaline-sonication, TAS: 15 min at 40 kHz and 80 °C, both based on the addition of 0.08 g NaOH per each g of total solid in the substrate), reaching 64-66% disintegration rate, and AD tests (5 %-wt dry substance) at 35 and 52 °C. Biogas yields were (for TA and TAS respectively): 0.22 and 0.20 Nm³/kg_VS (62-70% methane); 0.21 and 0.19 Nm³/kg_VS (66-66% methane) at 52 °C. At both temperatures, methane yields considerably improved (+71-100%), compared to mixed untreated substrates, and 5-8 %-wt total solids reductions were observed. A technical-economic scale-up assessment completed the research. The energy analysis highlighted the crucial role of TA pre-treatment in achieving the process energetic sustainability. The economic analysis showed that the AD of the considered cosmetic waste could be sustainable anyway, thanks to the savings related to the disposal of the digestate compared to current waste management costs.

Semi-continuous anaerobic digestion of mixed wastewater sludge with biochar addition

This work analysed the effects of Biochar (BC) addition to the Anaerobic digestion (AD) of wastewater Mixed sludge (MS) in semi-continuous mode. A 3 L digester was operated at 37 °C for 100 days, feeding MS collected every three weeks in the same wastewater treatment plant, and 10 g L^-1 of BC. The average performance of MS digestion (biogas 188 NmL d^-1, 68% methane) improved in presence of BC (biogas 244 NmL d^-1, 69% methane). According to the results of the multiple linear regression analysis performed on the experimental data, the 79% variation of the soluble COD in the MS was the driving factor for the 38% increase of biogas and methane yields. In conclusion, in the considered experimental conditions, the variability of the substrate's composition was the key factor driving the performances of the AD of MS, independently of the addition of BC.

Search for B^{+}→K^{+}νν[over ¯] Decays Using an Inclusive Tagging Method at Belle II

A search for the flavor-changing neutral-current decay B^{+}→K^{+}νν[over ¯] is performed at the Belle II experiment at the SuperKEKB asymmetric energy electron-positron collider. The data sample corresponds to an integrated luminosity of 63  fb^{-1} collected at the ϒ(4S) resonance and a sample of 9  fb^{-1} collected at an energy 60 MeV below the resonance. Because the measurable decay signature involves only a single charged kaon, a novel measurement approach is used that exploits not only the properties of the B^{+}→K^{+}νν[over ¯] decay, but also the inclusive properties of the other B meson in the ϒ(4S)→BB[over ¯] event, to suppress the background from other B meson decays and light-quark pair production. This inclusive tagging approach offers a higher signal efficiency compared to previous searches. No significant signal is observed. An upper limit on the branching fraction of B^{+}→K^{+}νν[over ¯] of 4.1×10^{-5} is set at the 90% confidence level.

Recovery of Waste Polyurethane from E-Waste-Part I: Investigation of the Oil Sorption Potential

The shredding of end-of-life refrigerators produces every year in Italy 15,000 tons of waste polyurethane foam (PUF), usually destined for energy recovery. This work presents the results of the investigation of the oil sorption potential of waste PUF according to ASTM F726-17 standard. Three oils (diesel fuel and two commercial motor oils) having different densities (respectively, 0.83, 0.87, and 0.88 kg/dm3) and viscosities (respectively, 3, 95, and 140 mm2/s at 40 °C) were considered. The waste PUF was sampled in an Italian e-waste treatment plant, and its characterization showed 16.5 wt% particles below 0.71 mm and 13 wt% impurities (paper, plastic, aluminum foil), mostly having dimensions (d) above 5 mm. Sieving at 0.071 mm was applied to the waste PUF to obtain a "coarse" (d > 0.71 mm) and a "fine" fraction (d < 0.71 mm). Second sieving at 5 mm allowed an "intermediate" fraction to be obtained, with dimensions between 0.71 and 5 mm. The oil sorption tests involved the three fractions of waste PUF, and their performances were compared with two commercial oil sorbents (sepiolite and OKO-PUR). The results of the tests showed that the "fine" PUF was able to retain 7.1-10.3 g oil/g, the "intermediate" PUF, 4.2-7.4 g oil/g, and the "coarse" PUF, 4.5-7.0 g oil/g, while sepiolite and OKO-PUR performed worse (respectively, 1.3-1.6 and 3.3-5.3 g oil/g). In conclusion, compared with the actual management of waste PUF (100 wt% sent to energy recovery), the amount destined directly to energy recovery could be limited to 13 wt% (i.e., the impurities). The remaining 87 wt% could be diverted to reuse for oil sorption, and afterward directed to energy recovery, considered as a secondary option.

POS0606 DISEASE ACTIVITY AND PATIENTS-REPORTED OUTCOMES AFTER SWITCHING BETWEEN IL-6 RECEPTOR INHIBITORS AND JAK INHIBITORS: AN ANALYSIS FROM THE CORRONA REGISTRY

Background:

Rheumatoid arthritis (RA) patients who fail therapy may be switched to any of the five classes of biological disease-modifying antirheumatic drugs (DMARDs) and targeted synthetic DMARDs, to meet treatment goals. Physicians may hesitate to switch between Janus Kinase inhibitors (JAKi) and interleukin-6 receptor inhibitors (IL-6Ri) since they both impact IL-6 signalling and due to limited data on switching between the two classes.

Objectives:

This retrospective, observational study based on the real-world Corrona RA registry aimed to describe the response in RA patients switching between IL-6Ri and JAKi.

Methods:

Adult RA patients who initiated either IL-6Ri or JAKi after November 2012 and had a six-month post-initiation follow-up visit were eligible. Patients in ‘Cohort A’ initiated an IL-6Ri following discontinuation of a JAKi and those in ‘Cohort B’ initiated a JAKi following discontinuation of an IL-6Ri. Disease activity measures and patient-reported outcomes (PROs) were evaluated at baseline and at six-month follow-up. Within each group, change from baseline was assessed for Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire (HAQ), pain, fatigue, tender joint count (TJC), swollen joint count (SJC), physician global assessment (MDGA), patient global assessment (PtGA) and morning stiffness duration. Proportion of patients achieving CDAI low disease activity (LDA), CDAI remission and minimal clinically important difference (MCID) for HAQ, pain, fatigue, MDGA, PtGA were assessed. Adjusted linear and logistic regression models were performed for between-group comparisons (Cohort A vs Cohort B) excluding initiators who switched therapy prior to six-month visit.

Results:

Cohorts A and B included 122 and 144 initiators, respectively. Patients who switched to

IL-6Ri (vs JAKi) were younger (mean [SD] age, 56.2 [11.3] vs 58.9 [12.6] years), had higher baseline CDAI (23.2 [12.9] vs 20.2 [12.8]), had higher prior use of ≥2 csDMARDs (75% vs 65%), and were less likely to initiate therapy as monotherapy (44% vs 50%).

In Cohort A, significant changes from baseline were observed for all continuous outcomes except HAQ and fatigue. In Cohort B, a significant improvement was observed only for patient-reported pain (Table 1).

Table 1.

Unadjusted Within-Group Change from Baseline to Six Months, Mean (95% CI), n

OutcomesCohort A, N = 122Cohort B, N = 144CDAI-4.7 (-7.6, -1.9), 109-2.4 (-5.2, 0.4), 116HAQ-0.0 (-0.1, 0.1), 105-0.1 (-0.1, 0.0), 118Patient-reported pain-8.2 (-13.4, -3.0), 109-5.9 (-11.5, -0.2), 120Patient-reported fatigue-4.4 (-9.0, 0.2), 109-1.7 (-6.6, 3.3), 117TJC-1.6 (-3.0, -0.1), 112-1.2 (-2.6, 0.3), 117SJC-1.5 (-2.5, -0.4), 112-0.4 (-1.3, 0.6),117MDGA-10.9 (-15.6, -6.3), 112-4.3 (-8.7, 0.2), 117PtGA-6.0 (-11.2, -0.8), 109-4.8 (-10.5, 0.8), 120Morning stiffness durationa-1.3 (-2.2, -0.5), 109-0.1 (-1.1, 0.8), 118

aAmong those reporting morning stiffness at baseline.

In the adjusted between-group comparison (data not shown) of change from baseline, there were no significant differences in clinical outcomes between Cohorts A and B.

In both cohorts, patients achieved CDAI LDA, CDAI remission, and MCIDs across other PROs (Figure 1). In the adjusted between-group comparison (data not shown), the results were similar with the exception of achievement of CDAI LDA among patients with moderate to high disease activity at baseline.

Figure 1.

Rates of CDAI LDA, CDAI Remission, and MCID for PROsa at Six Months

Conclusion:

In general, in both cohorts a substantial proportion of patients achieved CDAI LDA and MCID across PROs. Despite some overlap of JAKi and IL-6Ri therapies’ on the IL-6 pathway, there are some distinct mechanisms of action which may result in meaningful improvements for a subset of patients.

Acknowledgements:

Amy Praestgaard (Sanofi) contributed to the interpretation of the statistical analysis for this abstract. Medical writing support for this abstract was provided by Nupur Chaubey (Sanofi).

Disclosure of Interests:

Anisha Dua Speakers bureau: AbbVie, Consultant of: Consulting/advisory board for AbbVie, Novartis, and Chemocentryx, Employee of: Board member of Vasculitis foundation and Chicago Rheumatism Society, Kerri Ford Shareholder of: Sanofi, Employee of: Sanofi, Stefano Fiore Shareholder of: Sanofi, Employee of: Sanofi. In addition, Stefano Fiore has a patent EP 19306553.9; USPTO #s 62/799,698; 62/851,474; 62/935,395 issued, Dimitrios A Pappas Shareholder of: Corrona LLC, Consultant of: Sanofi, AbbVie, Gtech, Roche Hellas, and Novartis, Employee of: Corrona LLC. Board of directors, Corrona Research Foundation, Judson Janak: None declared, Taylor Blachley: None declared, Carla Roberts-Toler: None declared, Kelechi Emeanuru: None declared, Joel Kremer Consultant of: AbbVie, Lilly, Novartis, Pfizer, BMS, Genentech, Regeneron, Sanofi, and Corrona, Grant/research support from: AbbVie, Lilly, Novartis, and Pfizer, Alan Kivitz Shareholder of: Pfizer, Sanofi, GlaxoSmithKline, Gilead Sciences, Inc., and Novartis, Speakers bureau: Celgene, Merck, Lilly, Novartis, Pfizer, Sanofi, Flexion, and AbbVie, Consultant of: AbbVie, Boehringer Ingelheim, Flexion, Janssen, Pfizer, Sanofi, Regeneron, SUN Pharma Advanced Research, Gilead Sciences, Inc. In addition, Alan Kivitz reports other from Altoona Center for Clinical Research, PC, during the conduct of the study.

POS0594 MEANINGFUL IMPROVEMENT AND WORSENING IN PATIENTS WHO DO NOT ACHIEVE LDA AND SWITCH THERAPY TO A NEW BIOLOGIC OR TARGETED THERAPY: RESULTS FROM THE CORRONA REGISTRY

Background:

Guidelines recommend adjusting therapy in patients with rheumatoid arthritis (RA) who fail to reach and sustain low disease activity (LDA) or remission (disease control). Many factors can affect the decision to change therapy, including the potential for improvement as well as the fear of potential worsening or loss of improvement already achieved. Although data exist on response to treatment in patients who switch therapy, data addressing the likelihood of worsening are limited.

Objectives:

The aim of this analysis was to describe the demographic, clinical characteristics, and change in clinical outcomes in patients on biologic/targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs) who had some improvement in clinical disease activity index (CDAI) but did not achieve LDA after ~ 6-12 months of treatment and then switched to a different b/tsDMARD.

Methods:

This study included adult inadequately responding RA patients from the CORRONA registry who: (1) started a biologic or Janus kinase inhibitor (JAKi) between January 2010 to November 2020 (V1), (2) had any CDAI improvement (i.e., decrease ≥1 unit) but were not in LDA or remission at a subsequent visit (baseline [BL]) occurring 3 to 15 months after V1; (3) had a third visit (follow-up [F/U]) 6 (±3) months after BL with a valid CDAI measure; (4) switched therapy at the BL or between BL and F/U, with the switch occurring at least 3 months prior to the F/U. CDAI >10 and ≤22 was defined as moderate disease activity (MDA) and CDAI >22 was defined as high disease activity (HDA). Two thresholds of change in CDAI (≥6 and ≥12 units) were used to define meaningful improvement and meaningful worsening after the switch. If there was no meaningful improvement or meaningful worsening, this was considered as no meaningful change (-5 to +5 for 6 units change and -11 to +11 for 12 units change). These thresholds for meaningful change were set for all switchers regardless of their pre-switch CDAI value. Descriptive statistics were generated for demographic and clinical characteristics for the switchers at BL, and the change of clinical outcomes was evaluated from BL to F/U.

Results:

Of the 1,224 patients fulfilling the inclusion criteria, 93 (7.6%) switched therapy and 1,131 (92.4%) did not switch therampy after not achieving an adequate response on the initial b/tsDMARD. At BL, 42.5% and 70.0% of patients had no meaningful improvement to their prior therapy based on ≥6 and ≥12-unit change, respectively; mean (SD) age was 53.1 (14.0) years; duration of RA 10.7 (10.4) years; CDAI 22.2 (10.8); 81.7% were female; 64.5% had MDA, 35.5% had HDA; 21.5 % reported being disabled, 24.7% were current smokers, and 50% were obese. In terms of prior biologic use 57.0%, 22.6%, and 20.4% had been on 1, 2, and 3+, respectively. From BL to F/U, meaningful worsening occurred in 30.1% and 12.9% using a threshold of 6 and 12, respectively, with the remaining patients experiencing meaningful improvement or no meaningful change (Figure 1).

Figure 1.

Meaningful Worsening, Meaningful Improvement, and No Meaningful Change Based on CDAI Change Thresholds of ≥6 and ≥12 From BL to F/U (N=93)

Conclusion:

In our analysis, a large proportion of patients who initiated a biologic/JAKi and experienced some improvement but failed to attain LDA or remission, did not switch therapy within approximately a year. This analysis consisted of many patients who did not have a meaningful response to their prior biologic/JAKi, patients who had received multiple prior biologics, and a large portion of patients with poor prognostic factors. Despite this, the proportion of patients with meaningful worsening was low compared with most patients who had either meaningful improvement or no meaningful change. Additional research is warranted to understand the reasons for not switching and whether the likelihood of a meaningful change correlates with prior response, poor prognosis, or other factors.

Acknowledgements:

Amy Praestgaard (Sanofi) contributed to the statistical analysis for this abstract. Medical writing support for this abstract was provided by Krishna Kammari (Sanofi).

Disclosure of Interests:

Jeffrey Curtis Grant/research support from: and personal fees from AbbVie, Amgen, BMS, CORRONA, Eli Lily, Janssen, Myriad, Pfizer, Roche, Regeneron, Radius, UCB, outside the submitted work, Stefano Fiore Shareholder of: Sanofi, Employee of: Sanofi. In addition, he has a patent EP 19306553.9; USPTO #s 62/799,698; 62/851,474; 62/935,395 issued, Kerri Ford Shareholder of: Sanofi, Employee of: Sanofi, Judson Janak: None declared, Hong Chang: None declared, Dimitrios A Pappas Employee of: CORRONA LLC. He has previously acted as a consultant for Sanofi, Abbvie, Gtech Roche Hellas, and Novartis. He has an equity interest in CORRONA LLC. and is on the Board of directors of the CORRONA research foundation, Taylor Blachley: None declared, Kelechi Emeanuru: None declared, Vivian Bykerk Grant/research support from: reports grants from Amgen, BMS, UCB, and Novartis were given to institution, that grants from the NIH, PCORI, and CIHR were given to institutions which whom she is affiliated, and that she has received personal fees from Amgen, Gilead, BMS, Pfizer, Sanofi Aventis, Roche, UCB and Regeneron, outside the submitted work.

POS0638 DISEASE SEVERITY AND OUTCOMES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS WHO RECEIVE A NEWLY APPROVED BIOLOGIC: REAL-WORLD US EXPERIENCE WITH SARILUMAB FROM THE ACR RISE REGISTRY

Background:

Patients with rheumatoid arthritis (RA) who have received multiple biologics or targeted therapies over time tend to have more refractory and more severe disease, which may lead to worse clinical response to treatment.

Objectives:

We used data from the ACR RISE registry to assess whether disease severity was greater in those who received sarilumab shortly after its FDA approval (May 2017) than in subsequent time periods and to evaluate the effectiveness of sarilumab in populations with various degrees of disease severity.

Methods:

Patients with RA who initiated sarilumab treatment in the period 2017-2020 were identified in the ACR RISE registry and divided into Cohort 1 (2017, year of the FDA approval) and the calendar year-based Cohorts 2-4 (2018-2020). Patient demographics, RA-related features, and comorbidities were determined using data prior to sarilumab initiation. The cohorts were compared using chi-square test (categorical variables) and a nonparametric test (continuous variables). Sarilumab effectiveness was assessed using 3 cohorts assembled based on progressively restrictive criteria: Active Disease cohort (Clinical Disease Activity Index [CDAI] >10 or Routine Assessment of Patient Index Data 3 [RAPID3] >6, and C-reactive protein, if measured, ≥8 mg/L), TARGET Eligibility cohort (patients who satisfied enrolment criteria for TARGET,1 a Phase 3 sarilumab trial in patients with RA and an inadequate response to TNF inhibitors), and TARGET Baseline cohort (patients from TARGET Eligibility cohort with characteristics weighted to match those from the TARGET trial baseline,1 using the matching-adjusted indirect comparison method2). In all 3 effectiveness cohorts, mean changes in CDAI and RAPID3 at 6 and 12 months post-initiation of sarilumab were evaluated using a model adjusted for baseline score, age, sex, race, calendar year, and seropositivity.

Results:

A total of 2949 patients, treated by 585 rheumatologists, initiated sarilumab treatment in the period 2017–2020. The 4 yearly cohorts were relatively similar in terms of patients’ age, sex, race, and most clinical characteristics. However, patients receiving sarilumab shortly after FDA approval (Cohort 1) had more ambulatory visits, a greater number of previously used non-TNFi biologics (particularly tocilizumab), and a higher comorbidity burden, and were more likely to be current users of glucocorticoids or opioids than sarilumab initiators in the subsequent 3 years. In the 3 cohorts used to assess sarilumab effectiveness, the greatest improvement was observed in the TARGET Baseline cohort, which also had the greatest mean baseline CDAI score (43), compared with the other two (24 both).

Conclusion:

In this real-world cohort, we observed modest evidence for channeling of patients with greater RA severity and greater prior exposure to non-TNFi biologics to sarilumab shortly after its FDA approval. This cohort effect did not diminish the effectiveness of sarilumab. All cohorts showed improvement, with the greatest clinical improvement observed in the cohort with the highest baseline CDAI score who most closely resembled those enrolled in a phase 3 trial of patients with an inadequate response to TNF inhibitors.

References:

[1]Fleischmann R, et al. Arthritis Rheumatol 2017;69:277-290.

[2]Signorovitch JE et al. Value Health 2012;15:940-7.

Figure 1.

Adjusted improvements in CDAI and RAPID3

Acknowledgements:

This study was sponsored by Sanofi. Medical writing support was provided by Vojislav Pejović, PhD (Eloquent Medical Affairs, division of Envision Pharma Group) and funded by Sanofi.

Disclosure of Interests:

Stefano Fiore Employee of: Sanofi, Lang Chen: None declared, Cassie Clinton Consultant of: Information available in profile, Huifeng Yun Grant/research support from: Research support for Pfizer, Amy Praestgaard Employee of: Sanofi, Kerri Ford Employee of: Sanofi, Jeffrey Curtis Consultant of: Received consulting and research grants from AbbVie, Amgen, BMS, Lilly, Gilead, GSK, Janssen, Myriad, Pfizer, Roche, Samsung, Sandoz, Sanofi, UCB, Grant/research support from: Received consulting and research grants from AbbVie, Amgen, BMS, Lilly, Gilead, GSK, Janssen, Myriad, Pfizer, Roche, Samsung, Sandoz, Sanofi, UCB

µRANIA-V: an innovative solution for neutron detection in homeland security

Detection of neutrons is becoming of the utmost importance, especially in the studies of radioactive waste and in homeland security applications. The crisis of 3He availability has required the development of innovative techniques. One solution is to develop light gas detectors for neutron counting to be used as portals for ports and airports. The neutron is converted on the Boron-coated cathode, releasing a charged particle, whose passage can be identified by the gas detector. While several technologies have been deployed in the past, the project μRANIA-V (μRwell Advanced Neutron Identification Apparatus) aims to detect thermal neutrons by means of the μRwell technology, an innovative gas detector. The goal is to produce tiles to operate as portals in homeland security or for radioactive waste management. The technological transfer towards the industry has started, thus the production can be cost-effective also owing to a construction process relatively easier compared to similar apparatus. By reading directly the signals from the amplification stage, the neutrons can be counted with simplified electronics further reducing the total cost. In this paper, the project will be described, with details on the μRwell technology and on the neutron counting, on the test beam performed, and on the future plans.

Search for Axionlike Particles Produced in e^{+}e^{-} Collisions at Belle II

We present a search for the direct production of a light pseudoscalar a decaying into two photons with the Belle II detector at the SuperKEKB collider. We search for the process e^{+}e^{-}→γa, a→γγ in the mass range 0.2<m_{a}<9.7  GeV/c^{2} using data corresponding to an integrated luminosity of (445±3)  pb^{-1}. Light pseudoscalars interacting predominantly with standard model gauge bosons (so-called axionlike particles or ALPs) are frequently postulated in extensions of the standard model. We find no evidence for ALPs and set 95% confidence level upper limits on the coupling strength g_{aγγ} of ALPs to photons at the level of 10^{-3}  GeV^{-1}. The limits are the most restrictive to date for 0.2<m_{a}<1  GeV/c^{2}.

Comparison between measurement and calculations for a 14 MeV neutron water activation experiment

The nuclear heat loads due to gamma rays emitted from the decay of 16N and delayed neutrons from17N, generated by the activation of water in cooling circuits, are critical for ITER design. The assessment of nuclear heating from activated water is complex; it requires temporal and spatial dependent transport and activation calculations taking into account variation of irradiation, water flow conditions and cooling circuits’ parameters. A water activation experiment has been recently conducted at the14 MeV Frascati Neutron Generator (FNG) in order to validate the methodology for water activation assessment used for ITER and to reduce the safety factors applied to the calculation results, which have a large impact on the schedule, commissioning and licensing. Water circulating inside an ITER First Wall (FW) mock-up was irradiated with 14 MeV neutrons and then measured using a large CsI scintillator detector. The system consists of a closed water loop where the cooling water, transiting through an ITER FW mock-up, is irradiated by FNG. The induced 16N activity via 14 MeV neutrons interactions with 16O via the 16O(n,p)16N reaction is measured in a dedicated counting station via an expansion volume. The water then passes to a much larger holding delay tank, and after several 16N half-lives decay time, it is then recirculated and exposed again to neutrons in the ITER First Wall (FW) mock-up. The measured 16N activity is obtained measuring the emitted characteristic 6.13 and 7.12 MeV gamma-rays. Calculations were performed in an accurate model of the FW mock-up using the MCNP Monte Carlo code and FENDL-3.1 nuclear data library to obtain the predicted flux impinging on the water. The EASY-2007 inventory code was used to predict the 16N activity. In this work, a comparison between measurements and calculations is reported together with associated uncertainty analysis.

SAT0100 ASSOCIATION BETWEEN LOW HEMOGLOBIN AND RADIOGRAPHIC PROGRESSION OVER 52 WEEKS IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM A PHASE 3 TRIAL OF SARILUMAB

Background:

Anemia is a common comorbidity in patients with rheumatoid arthritis (RA).

Objectives:

Assess whether low hemoglobin (Hb) identifies a subgroup of patients at increased risk of joint damage progression, and investigate whether sarilumab modulates this risk.

Methods:

The 52-week, double-blind, Phase 3 MOBILITY trial (NCT01061736) in patients with active RA and inadequate response to methotrexate (n = 1197) demonstrated the tolerability and efficacy (clinical and radiographic) of subcutaneous sarilumab 150 and 200 mg every 2 weeks versus placebo, both in combination with methotrexate (MTX). In thispost hocanalysis, baseline characteristics and radiographic outcomes in MOBILITY were analyzed by baseline Hb category (low or normal) according to World Health Organization criteria, with low Hb defined as <120 g/L for women and <130 g/L for men. NominalPvalues are presented.

Results:

A total of 414 patients (35%) had low Hb at baseline. Patients with low Hb were more likely than patients with normal Hb to be female (86% vs 79%, respectively), Asian (14% vs 5%), younger (mean age 49 vs 51 years), and to have lower body weight (mean 69 vs 77 kg); all nominalP<0.01. Duration of RA, prior biologic use, rheumatoid factor positivity, and baseline tender and swollen joint counts were similar between patients with low and normal baseline Hb, but there was a nominally significant difference in C-reactive protein (mean 30.2 [SD 28.5] vs 17.3 [18.5] mg/L;P<0.0001). Patients with low Hb generally exhibited more joint damage progression over 52 weeks than patients with normal Hb (Table). In the sarilumab + MTX groups, joint damage progression was mitigated compared with placebo + MTX in patients with low Hb and in patients with normal Hb. Mean change from baseline in Hb at 52 weeks in the placebo + MTX, sarilumab 150 mg + MTX, and sarilumab 200 mg + MTX groups was +3.7 (SD 10.8), +14.7 (12.1), and +14.0 (10.5) g/L, respectively, in patients with low Hb at baseline, and –2.5 (9.9), +6.2 (9.3), and +8.0 (9.9) g/L in patients with normal Hb at baseline.

Table.

Mean change from baseline (SD) in radiographic measures of joint damage

Placebo+ MTXSarilumab 150 mg+ MTXSarilumab 200 mg+ MTXLow Hb (n = 140)Normal Hb (n = 258)Low Hb (n = 145)Normal Hb (n = 255)Low Hb (n = 129)Normal Hb (n = 270)mTSS3.75 (9.00)2.29 (6.98)1.20*** (5.58)0.73** (4.07)0.60*** (4.13)0.08*** (4.83)Joint space narrowing1.52 (3.71)1.22 (3.92)0.79* (3.17)0.30** (2.70)0.50** (2.93)0.06*** (3.33)Erosion score2.24 (6.24)1.07 (3.91)0.41*** (3.18)0.44* (2.05)0.10*** (2.13)0.02*** (2.19)

NominalP*<0.05, **<0.01, ***<0.001 versus placebo by rank ANCOVA model stratified by prior biologic use and region; mTSS, modified total Sharp score

Conclusion:

Overall, sarilumab slowed joint damage progression in patients with RA. Additionally, in those patients with low Hb, who may suffer greater damage than those with normal Hb, sarilumab also increased Hb.

Acknowledgments:

Study funding and medical writing support (Matt Lewis, PhD, of Adelphi Communications Ltd, Macclesfield, UK) were provided by Sanofi Genzyme (Cambridge, MA, USA) and Regeneron Pharmaceuticals, Inc. (Tarrytown, NY, USA) in accordance with Good Publication Practice (GPP3) guidelines.

Disclosure of Interests:

Gerd Rüdiger Burmester Consultant of: AbbVie Inc, Eli Lilly, Gilead, Janssen, Merck, Roche, Pfizer, and UCB Pharma, Speakers bureau: AbbVie Inc, Eli Lilly, Gilead, Janssen, Merck, Roche, Pfizer, and UCB Pharma, Jean-Pierre Morello Shareholder of: Regeneron Pharmaceuticals, Inc., Employee of: Regeneron Pharmaceuticals, Inc., Owen Hagino Shareholder of: Sanofi, Employee of: Sanofi, Amy Praestgaard Employee of: Sanofi Genzyme, Stefano Fiore Shareholder of: Sanofi, Employee of: Sanofi, Mark C. Genovese Grant/research support from: Abbvie, Eli Lilly and Company, EMD Merck Serono, Galapagos, Genentech/Roche, Gilead Sciences, Inc., GSK, Novartis, Pfizer Inc., RPharm, Sanofi Genzyme, Consultant of: Abbvie, Eli Lilly and Company, EMD Merck Serono, Genentech/Roche, Gilead Sciences, Inc., GSK, Novartis, RPharm, Sanofi Genzyme

Search for an Invisibly Decaying Z^{'} Boson at Belle II in e^{+}e^{-}→μ^{+}μ^{-}(e^{±}μ^{∓}) Plus Missing Energy Final States

Theories beyond the standard model often predict the existence of an additional neutral boson, the Z^{'}. Using data collected by the Belle II experiment during 2018 at the SuperKEKB collider, we perform the first searches for the invisible decay of a Z^{'} in the process e^{+}e^{-}→μ^{+}μ^{-}Z^{'} and of a lepton-flavor-violating Z^{'} in e^{+}e^{-}→e^{±}μ^{∓}Z^{'}. We do not find any excess of events and set 90% credibility level upper limits on the cross sections of these processes. We translate the former, in the framework of an L_{μ}-L_{τ} theory, into upper limits on the Z^{'} coupling constant at the level of 5×10^{-2}-1 for M_{Z^{'}}≤6  GeV/c^{2}.

A review of nature-based solutions for greywater treatment: Applications, hydraulic design, and environmental benefits

Recognizing greywater as a relevant secondary source of water and nutrients represents an important chance for the sustainable management of water resource. In the last two decades, many studies analysed the environmental, economic, and energetic benefits of the reuse of greywater treated by nature-based solutions (NBS). This work reviews existing case studies of traditional constructed wetlands and new integrated technologies (e.g., green roofs and green walls) for greywater treatment and reuse, with a specific focus on their treatment performance as a function of hydraulic operating parameters. The aim of this work is to understand if the application of NBS can represent a valid alternative to conventional treatment technologies, providing quantitative indications for their design. Specifically, indications concerning threshold values of hydraulic design parameters to guarantee high removal performance are suggested. Finally, the existing literature on life cycle analysis of NBS for greywater treatment has been examined, confirming the provided environmental benefits.

Classification of plastic waste originated from waste electric and electronic equipment based on the concentration of antimony

The aim of this research is a preliminary assessment of antimony concentration in plastic fractions deriving from different e-waste. We considered microwave ovens, desktop computers, laptops, mobile phones, a TV case, a PC monitor and LED lamps (63 items in total). The plastic fraction ranged from 8%-wt in computers and microwave ovens, up to 40%-wt in cell phones and 59%-wt in LED lamps. Specific polymers were identified through Near Infrared spectroscopy. The samples followed three parallel procedures: acid digestion with aqua regia; conversion into ashes at 600 °C then acid digestion with aqua regia; leaching according to UNI10802 reference procedure. Plastic components with significant amounts of antimony were the ones derived from desktop computers (25-1900 mg/kg) and from microwave ovens (830 mg/kg), yet their relative amount compared to the total weight of the item was limited. Items with larger plastic fractions showed lower concentrations of antimony (1-6 mg/kg in mobile phones cases and 160-640 mg/kg in plastic components of LED lamps). Leaching tests revealed that the analyzed plastic fractions could be mostly admitted in non-hazardous waste landfills. The analysis of ashed samples highlighted the need to further improve the acidic extraction procedure.

Techno-economic assessment of non-sterile batch and continuous production of lactic acid from food waste

Non-sterile lactic acid (LA) fermentation of highly viscous food waste was demonstrated in batch and continuous flow fermentations. With Streptococcus sp., an indigenous consortium, and/or applied glucoamylase, food waste was fermented without addition of external carbon or nitrogen sources. Experimental results were used for economic and energy evaluations under consideration of different catchment area sizes from 50,000 to 1,000,000 inhabitants. During batch mode, addition of glucoamylase resulted in a titer (after 24 h), yield, and productivity of 50 g L^-1, 63%, and 2.93 g L^-1h^-1, respectively. While titer and yield were enhanced, productivity was lower during continuous operation and 69 g L^-1, 86%, and 1.27 g L^-1h^-1 were obtained at a dilution rate of 0.44 d^-1 when glucoamylase was added. Both batch and continuous flow fermentations were found economically profitable with food waste from 200,000 or more inhabitants.

Improving waste electric and electronic equipment management at full-scale by using material flow analysis and life cycle assessment

This work has as main objective the analysis of waste from electric and electronic equipment (WEEE or e-waste) management through material flow analysis and life cycle assessment of a full-scale Italian facility that is significant about the e-waste flows treated (9900 t/y) and representative of a developed EU country about the industrial process outline, based on manual dismantling phases and physic-mechanical automatic processes. Three WEEE categories (i.e. R1-Cooling equipment, R2-Large household appliances and R3- TVs and screens) have been chosen with the reason that they are the most abundant in EU. The methodology was based on two end-of-life scenarios: S₀-partial recycling of valuable fractions and landfilling of the rest, which is conventional e-waste processing in Italian facilities; S₁-complete recycling of valuable fractions, limited incineration and landfilling of the rest, which describes what happens in the considered case study. Mass balance of the three treatment lines showed recycling rate (RR) values equal to: for R1 40% for S₀ and 80% for S₁; for R2 65% for S₀ and 99% for S₁; for R3 86% for S₀ and 91% for S₁, with significant fractions incinerated or landfilled only for R1 treatment line. Life cycle assessment considered transport (post-consumer collection), treatment, recycling, incineration and disposal. As main results, eco-toxicity aquatic potentials referring to marine and fresh water were the most relevant impact categories. In conclusion, recycling (mostly of metals) played a crucial role for environmental benefits, and transport and polyurethane plus rubber incineration for the environmental impacts.

Assessment of plastic waste materials degradation through near infrared spectroscopy

Plastic waste is a relevant challenge for waste management sector and further technological means have to be urgently researched. The evaluation of plastic waste quality through non-destructive, cost-effective and mature technologies could be without any doubt a key issue. This study is aimed at the assessment of Near Infrared (NIR) spectroscopy for the generation of global degradation-prediction models able to forecast plastic ageing. The degradation of Polyethylene terephthalate (PET), Acrylonitrile Butadiene Styrene (ABS), Polypropylene (PP) and Polyethylene (PE) was achieved by thermal ageing (at 85 °C, 105 °C and 120 °C and durations ranging from 4 to 504 h), to simulate environmental outdoor conditions. Experimental data obtained for each plastic material were elaborated through partial least square (PLS) regression to obtain empirical models. For all inspected plastic materials, a good correspondence between the variation in absorbance units and the change in chemical bonds vibrations was observed. The PLS models were afterwards calibrated (taking into account the different ageing conditions; first separately then including the ageing factors combined). A high accuracy (R² equal to 0.85-1.00) was observed in predicting ageing for PET and ABS, while the correspondence showed a 30% decrease for PE and PP. This study proves that NIR spectroscopy can be recommended as an effective tool to investigate plastics degradation, with some limitations for specific polymers that need further investigations.

Assessment of the waste electrical and electronic equipment management systems profile and sustainability in developed and developing European Union countries

The assessment of waste management systems for electrical and electronic equipment (WEEE) from developed economies (Germany, Sweden and Italy) and developing countries (Romania and Bulgaria), is discussed covering the period 2007-2014. The WEEE management systems profiles are depicted by indicators correlated to WEEE life cycle stages: collection, transportation and treatment. The sustainability of national WEEE management systems in terms of greenhouse gas emissions is presented, together with the greenhouse gas efficiency indicator that underlines the efficiency of WEEE treatment options. In the countries comparisons, the key elements are: robust versus fragile economies, the overall waste management performance and the existence/development of suitable management practices on WEEE. Over the life cycle perspective, developed economies (Germany, Sweden and Italy) manage one order of magnitude higher quantities of WEEE compared to developing countries (Romania and Bulgaria). Although prevention and reduction measures are encouraged, all WEEE quantities were larger in 2013, than in 2007. In 2007-2014, developed economies exceed the annual European collection target of 4 kg WEEE/capita, while collection is still difficult in developing countries. If collection rates are estimated in relationship with products placed on market, than similar values are registered in Sweden and Bulgaria, followed by Germany and Italy and lastly Romania. WEEE transportation shows different patterns among countries, with Italy as the greatest exporter (in 2014), while Sweden treats the WEEE nationally. WEEE reuse is a common practice in Germany, Sweden (from 2009) and Bulgaria (from 2011). By 2014, recycling was the most preferred WEEE treatment option, with the same kind of rates performance, over 80%, irrespective of the country, with efforts in each of the countries in developing special collection points, recycling facilities and support instruments. The national total and the recycling carbon footprints of WEEE are lower in 2013 than in 2007 for each country, the order in reducing the environmental impacts being: Germany, Italy, Sweden, Bulgaria and Romania. The negative values indicate savings in greenhouse gas emissions. In 2013, the GHG efficiency shows no differences of the WEEE management in the developed and developing countries.

A Web Service-based Grid Portal for Edgebreaker Compression

Background: In health applications, and elsewhere, 3D data sets are increasingly accessed through the Internet. To reduce the transfer time while maintaining an unaltered 3D model, adequate compression and decompression techniques are needed. Recently, Grid technologies have been integrated with Web Services technologies to provide a framework for interoperable application-to-application interaction.

Objectives: The paper describes an implementation of the Edgebreaker compression technique exploiting web services technology and presents a novel approach for using such services in a Grid Portal. The Grid portal, developed at the CACT/ISUFI of the University of Lecce, allows the processing and delivery of biomedical images (CT – computerized tomography – and MRI – magnetic resonance images) in a distributed environment, using the power and security of computational Grids.

Methods: The Edgebreaker Compression Web Service has been deployed on a Grid portal and allows compressing and decompressing 3D data sets using the Globus toolkit GSI (Globus Security Infrastructure) protocol. Moreover, the classical algorithm has been modified extending the compression to files containing more than one object.

Results and Conclusions: An implementation of the Edgebreaker compression technique and related experimental results are presented. A novel approach for using the compression web service in a Grid portal allowing storing and preprocessing of huge 3D data sets, and subsequent efficient transmission of results for remote visualization is also described.

Lipoxin A4 and Serum Amyloid a Differentially Modulate Phospholipase D in Human Fibroblast-Like Synoviocytes

Lipoxin A4 (LXA4) and scrum amyloid A (SAA) are endogenous negative and positive modulators of inflammation, respectively. Both molecules bind the shared lipoxin A4 receptor (ALX) and elicit opposing effects on the production of inflammatory cytokines and matrix metalloproteinases. The aim of these studies is to examine the divergence of the intracellular signaling pathways triggered by lipid LXA4 (1 nM) and protein SAA (200 nM) ligands of ALX. Phospholipase D (PLD) is a phosphohydrolase enzyme that catalyzes the generation of phosphatidic acid (PA) from membrane phospholipids. Our results showed that in fibroblast-like synoviocytes, activation of PLD occurred only in response to LXA4, and not SAA. PA (30 μM) mimicked LXA4 and demonstrated inhibition of IL-8 production induced by SAA or interleukin-1β. In sharp contrast to LXA4, SAA confirmed the stimulation of IL-8 release as determined previously. Taken together, these findings suggest that two physiologic ligands sharing the common ALX receptor, LXA4 and SAA, differentially regulate the level of PLD activation and differentially modulate IL-8. These results may have important implications for understanding the regulation of inflammatory responses under physiologic and pathological conditions.

Investigation of food waste valorization through sequential lactic acid fermentative production and anaerobic digestion of fermentation residues

This work concerns the investigation of the sequential production of lactic acid (LA) and biogas from food waste (FW). LA was produced from FW using a Streptococcus sp. strain via simultaneous saccharification and fermentation (SSF) and separate enzymatic hydrolysis and fermentation (SHF). Via SHF a yield of 0.33g_LA/g_FW (productivity 3.38g_LA/L·h) and via SSF 0.29g_LA/g_FW (productivity 2.08g_LA/L·h) was obtained. Fermentation residues and FW underwent anaerobic digestion (3wt% TS). Biogas yields were 0.71, 0.74 and 0.90Nm³/kg_VS for FW and residues from SSF and SHF respectively. The innovation of the approach is considering the conversion of FW into two different products through a biorefinery concept, therefore making economically feasible LA production and valorising its fermentative residues. Finally, a mass balance of three different outlines with the aim to assess the amount of LA and biogas that may be generated within different scenarios is presented.

Opposing Regulation of Interleukin-8 and NF-kB Responses by Lipoxin A4 and Serum Amyloid a via the Common Lipoxin a Receptor

Lipoxin A4 (LXA4) is a potent eicosanoid that inhibits IL-1β-induced activation of human fibroblast-like synoviocytes (FLS) via the LXA4 receptor (ALXR). Serum amyloid A (SAA) is an acute phase reactant with cytokine-like properties. SAA has been shown to bind the same seven transmembrane G protein-coupled receptor ligated by LXA4. Here we compared the inflammatory responses of lipid (LXA4) and peptide (SAA) ligands in human FLS via the shared ALX and characterized their downstream signaling. LXA4 induced stimulation of tissue inhibitors of metalloproteinase-2, whereas SAA induced interleukin-8 and matrix metalloproteinase-3 production. SAA up-regulated NF-kB and AP-1 DNA binding activity, while LXA4 markedly inhibited these responses after IL-1β stimulation. A human IL-8 promoter luciferase construct was transfected into CHO cells stably expressing ALXR in order to determine the role of NF-kB and/or AP-1 in the regulation of IL-8 gene expression. The NF-kB pathway proved to be the preeminent for the biological responses elicited by both ligands. These findings suggest that two endogenous molecules, targeting a common receptor, could participate in the pathogenesis of inflammatory arthritis by differentially regulating inflammatory responses in tissues expressing the ALXR.

Lipoxin A4 Counteracts Synergistic Activation of Human Fibroblast-like Synoviocytes

Excessive production of interleukin-6 (IL-6) and metalloproteinases (MMPs) has been implicated in the pathogenesis of rheumatoid arthritis. Lipoxin A4 (LXA4) and transforming growth factor (32 (TGF-|32) have potential anti-inflammatory activities; these two mediators were tested to determine how they affect IL-1β-dependent release of IL-6 and MMPs in human fibroblast-like synoviocytes. The results revealed dramatic differences between the mediators: TGF-β2 acted synergistically with IL-1β to stimulate IL-6 protein levels, whereas LXA4 inhibited IL-6 expression in a dose- and time-dependent manner. Inhibition, by LXA4 was abrogated when cells were pre-incubated with antibody against the ALXR (Lipoxin A4 Receptor) TGF-β2 by itself had no significant effect on IL-6 or MMP levels. LXA4, at nanomolar concentrations, altered the MMP-1 and MMP-3 expression levels of IL-1β and TGF-β2 stimulated fibroblast-like synoviocytes. Furthermore, IL-1β and TGF-β2 up-regulated ALXR mRNA. These results demonstrate, for the first time, that ALXR mediate the effects of LXA4 on inflammatory responses after stimulation of fibroblast-like synoviocytes with IL-1β plus TGF-β2. These activities might constitute an important mechanism by which LXA4 regulates synovial fibroblast activation.

Aerosol composition and properties variation at the ground and over the column under different air masses advection in South Italy

Aerosol composition and properties variation under the advection of different air masses were investigated, as case studies, by contemporary measurements over the atmospheric column and at the ground in a semi-rural site in South Italy. The absence of local strong sources in this area allowed to characterize background aerosol and to compare particle mixing effects under various atmospheric circulation conditions. Aerosol optical depth (AOD) and Ǻngström parameters from radiometric measurements allowed the detection and identification of polluted, dust, and volcanic atmospheric conditions. AODs were the input for a suitable model to evaluate the columnar aerosol composition, according to six main atmospheric components (water-soluble, soot, sea salt accumulation, sea salt coarse, mineral dus,t and biological). Scanning electron microscope (SEM) analysis of particulate sampled with a 13-stage impactor at the ground showed not only fingerprints typical of the different air masses but also the effects of transport and aging on atmospheric particles, suggesting processes that changed their chemical and optical properties. Background columnar aerosol was characterized by 72% of water-soluble and soot, in agreement with ground-based findings that highlighted 60% of contribution from anthropogenic carbonate particles and soot. In general, a good agreement between ground-based and columnar results was observed. Under the advection of trans-boundary air masses, water-soluble and soot were always present in columnar aerosol, whereas, in variable percentages, sea salt and mineral particles characterized both dust and volcanic conditions. At the ground, sulfates characterized the amorphous matrix produced in finer stages by the evaporation of solutions of organic and inorganic aerosols. Sulfates were also one of the key players involved in heterogeneous chemical reactions, producing complex secondary aerosol, as such clay-sulfate internally mixed particle externally mixed with soot chains.

An automatized system for the assessment of nutritive sucking behavior in infants: a preliminary analysis on term neonates

Nutritive Sucking (NS) is a highly organized process that can reflect infants' maturation during the early post-natal period. The assessment of NS may provide a sensitive means of evaluating early motor skills and their development. Thus, a reliable tool for assessing sucking behavior may benefit diagnostics and treatment of newborns since the first days of life. The aim of this work is to propose an automatized system to measure sucking ability and calculate a set of objective and quantitative indices for its assessment. We focused on the analysis of the Intraoral Pressure (IP) generated by infants while feeding: an ad-hoc designed software application was developed to analyze the signal obtained by a pressure transducer connected with a catheter placed through a standard bottle teat into the oral cavity during feeding. Automatic algorithms for suck and burst identification and for their characterization are described. We carried out a preliminary test of the system, analyzing data from two healthy term newborns, tested twice over time (1-2 days old and 6-10 weeks later). We calculated a set of different sucking parameters (e.g. sucking amplitude, frequency and area), and proposed some indices, that are typically used for the assessment of motor control, in order to assess the smoothness of IP. Results encourage further investigation of the proposed system for monitoring the development of early sucking skills.

Characterization of crumb rubber from end-of-life tyres for paving applications

Crumb rubber (CR) derived from grinding of end-of-life tyres (ELTs) may be successfully used as a bitumen modifier or as a supplementary component in the production of bituminous mixtures employed for the construction and maintenance of road pavements. However, CRs deriving from different sources and production processes yield effects on performance of corresponding paving mixtures under traffic loading and on gaseous emissions produced during laying on site which may change considerably depending upon their physical and chemical properties. In order to quantitatively assess the possible variability of CR characteristics, 16 samples were taken from 9 Italian and 2 foreign ELT processing plants. Investigation activities included field surveys, during which plants were examined in detail, and laboratory tests, which focused on physical and chemical characterization of CR. Based on the analysis of available technical information and experimental data, it was possible to find relationships between the peculiar characteristics of treatment cycles and corresponding CR properties.

Scale effect of anaerobic digestion tests in fed-batch and semi-continuous mode for the technical and economic feasibility of a full scale digester

Methane production capacity in mesophilic conditions of waste from two food industry plants was assessed in a semi-pilot (6L, fed-batch) and pilot (300 L, semi-continuous) scale. This was carried out in order to evaluate the convenience of producing heat and electricity in a full scale anaerobic digester. The pilot test was performed in order to obtain more reliable results for the design of the digester. Methane yield, returned from the pilot scale test, was approximately 80% of that from the smaller scale test. This outcome was in line with those from other studies performed in different scales and modes and indicates the success of the pilot scale test. The net electricity produced from the digester accounted for 30-50% of the food industry plants' consumption. The available thermal energy could cover from 10% to 100% of the plant requirements, depending on the energy demand of the processes performed.

Review of Italian experience on automotive shredder residue characterization and management

Automotive Shredder Residue (ASR) is a special waste that can be classified as either hazardous or non hazardous depending on the amount of hazardous substances and on the features of leachate gathered from EN12457/2 test. However both the strict regulation concerning landfills and the EU targets related to End-of-Life Vehicles (ELVs) recovery and recycling rate to achieve by 2015 (Directive 2000/53/EC), will limit current landfilling practice and will impose an increased efficiency of ELVs valorization. The present paper considers ELVs context in Italy, taking into account ASRs physical-chemical features and current processing practice, focusing on the enhancement of secondary materials recovery. The application in waste-to-energy plants, cement kilns or metallurgical processes is also analyzed, with a particular attention to the possible connected environmental impacts. Pyrolysis and gasification are considered as emerging technologies although the only use of ASR is debatable; its mixing with other waste streams is gradually being applied in commercial processes. The environmental impacts of the processes are acceptable, but more supporting data are needed and the advantage over (co-)incineration remains to be proven.

A novel radioguided surgery technique exploiting β(-) decays

The background induced by the high penetration power of the radiation is the main limiting factor of the current radio-guided surgery (RGS). To partially mitigate it, a RGS with β⁺-emitting radio-tracers has been suggested in literature. Here we propose the use of β⁻-emitting radio-tracers and β⁻ probes and discuss the advantage of this method with respect to the previously explored ones: the electron low penetration power allows for simple and versatile probes and could extend RGS to tumours for which background originating from nearby healthy tissue makes probes less effective. We developed a β⁻ probe prototype and studied its performances on phantoms. By means of a detailed simulation we have also extrapolated the results to estimate the performances in a realistic case of meningioma, pathology which is going to be our first in-vivo test case. A good sensitivity to residuals down to 0.1 ml can be reached within 1 s with an administered activity smaller than those for PET-scans thus making the radiation exposure to medical personnel negligible.

Strategies for the enhancement of automobile shredder residues (ASRs) recycling: results and cost assessment

With reference to the European regulation about the management of End-of-Life Vehicles (ELVs), Directive 2000/53/EC imposes the achievement of a recycling target of 85%, and 95% of total recovery by 2015. Over the last few years many efforts have been made to find solutions to properly manage the waste coming from ELVs with the aim of complying with the targets fixed by the Directive. This paper focuses on the economical evaluation of a treatment process, that includes physical (size and density), magnetic and electrical separations, performed on the light fraction of the automobile shredder residue (ASR) with the aim of reducing the amount of waste to dispose of in a landfill and enhancing the recovery of valuable fractions as stated by the EU Directive. The afore mentioned process is able to enhance the recovery of ferrous and non-ferrous metals of an amount equal to about 1% b.w. (by weight) of the ELV weight, and to separate a high energetic-content product suitable for thermal valorization for an amount close to (but not higher than) 10% b.w. of the ELV weight. The results of the economical assessment led to annual operating costs of the treatment ranging from 300,000 €/y to 350,000 €/y. Since the considered plant treats about 13,500 metrictons of ASR per year, this would correspond to an operating cost of approximately 20-25 €/t. Taking into account the amount and the selling price of the scrap iron and of the non magnetic metal recovered by the process, thus leading to a gain of about 30 €/t per ton of light ASR treated, the cost of the recovery process is balanced by the profit from the selling of the recovered metals. On the other hand, the proposed treatment is able to achieve the fulfillment of the targets stated by Directive 2000/53/EC concerning thermal valorization and reduce the amount of waste generated from ELV shredding to landfill.